58981-35-4

Basic information

• Product Name: 2-(4-METHYL-THIAZOL-5-YL)-ETHYLAMINE
• Synonyms: 2-(4-METHYL-THIAZOL-5-YL)-ETHYLAMINE;RARECHEM AN KA 1403;2-(4-METHYL-1,3-THIAZOL-5-YL)ETHANAMINE;4-METHYL-5-THIAZOLEETHANAMINE;2-(4-Methylthiazol-5-yl)ethylamine oxalic acid;2-(4-methylthiazol-5-yl)ethanamine;2-(4-methyl-1,3-thiazol-5-yl)ethanamine(SALTDATA: 2HBr);[2-(4-Methyl-1,3-thiazol-5-yl)ethyl]amine dihydrochloride
• CAS NO: 58981-35-4
• Molecular Formula: C₆H₁₀N₂S
• Molecular Weight: 142.22
• Product Categories: Building Blocks;Thiazole
• Mol File: 58981-35-4.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 244.8 °C at 760 mmHg
• Flash Point: 101.9 °C
• Appearance: /
• Density: 1.138 g/cm³
• Vapor Pressure: 0.0297mmHg at 25°C
• Refractive Index: 1.564
• Storage Temp.: 2-8°C
• Solubility: Chloroform (Slightly), DMSO (Sparingly), Methanol (Sparingly)
• CAS DataBase Reference: 2-(4-METHYL-THIAZOL-5-YL)-ETHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-METHYL-THIAZOL-5-YL)-ETHYLAMINE(58981-35-4)
• EPA Substance Registry System: 2-(4-METHYL-THIAZOL-5-YL)-ETHYLAMINE(58981-35-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 58981-35-4(Hazardous Substances Data)

Usage

Uses

2-(4-Methylthiazol-5-yl)ethanamine is used in the synthesis and biological testing of several new H2 (Histamine) agonists.

InChI:InChI=1/C6H10N2S/c1-5-6(2-3-7)9-4-8-5/h4H,2-3,7H2,1H3

Upstream product

• 50382-33-7 (4-methyl-1,3-thiazol-5-yl)acetonitrile 
• 854473-13-5 3-(4-methyl-thiazol-5-yl)-propionic acid amide 
• 6508-39-0 3-(4-methyl-thiazol-5-yl)-propionic acid ethyl ester 
• 153805-36-8 5-(2-azidoethyl)-4-methylthiazole 
• 122-39-4 diphenylamine 
• 1759-28-0 4-methyl-5-vinylthiazole 
• 533-45-9 chlormethiazole 
• 406727-23-9 (4-methyl-thiazol-5-yl)-acetic acid ethyl ester 
• 136384-13-9 (4-methyl-thiazol-5-yl)-acetic acid amide 
• 137-00-8 5-hydroxyethyl-4-methylthiazole 
• 36956-91-9 4-methyl-5-(β-phthalimidoethyl)thiazole 

Downstream Products

• 137-00-8 5-hydroxyethyl-4-methylthiazole 
• 153805-39-1 L-idonamide, 6-cyclohexyl-2,5,6-trideoxy-5-amino-2-(1-methylethyl)-N-<2-methyl-1-<<<2-(4-methyl-5-thiazolyl)ethyl>amino>carbonyl>butyl>-, <3aS-<3aα,4β(1R*,2R*),6aα>>- 
• 153805-38-0 carbamic acid, <1-<2,2-dimethyl-5-<2-cyclohexyl-1-<<<2-methyl-1-<<(2-pyridinylmethyl)amino>carbonyl>butyl>amino>carbonyl>ethyl>-1,3-dioxolan-4-yl>-2-methylpropyl>-, 1,1-dimethylethyl ester, <4R-<4α(R*),5β(S*)>> 

Relevant articles and documents

-

-

Evaluation of a Vitamin-Cloaking Strategy for Oligopeptide Therapeutics: Biotinylated HIV-1 Protease Inhibitors

The outstanding limitations to the oligopeptide as a therapeutic agent are poor oral availability and rapid biliary clearance.To address these concerns a series of eight peptidic HIV-1 protease inhibitors containing the structural segment of the vitamin b